Universitair Medisch Centrum Utrecht — Sponsor Intelligence | 37 EU Trials

Filter these 37 trials by condition, phase, country and more.

Open in Search →

37 Registered trials

17 Recruiting

14 Completed trials

15 Countries active

103 Unique IMPs

100% Results reported

Phase III

Phase II

Phase III/IV

Phase IV

Phase I (Other)

Phase III: 12 Phase II: 8 Phase I/II: 1 Phase III/IV: 5 Phase IV: 5 Phase I: 1 Phase I (Other): 4 Phase I (FiH): 1

Oversight events:

3 serious breaches 1 temporary halt 1 unexpected event 1 corrective measure across 5 trials

View oversight register →

100%

14 of 14 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Colorectal cancer metastatic 2 Peripheral artery surgery 1 Schizophrenia 1 Brain injury 1 Endometrial cancer stage II 1 Peripheral artery stenosis 1 Schizoaffective disorder 1 Squamous cell carcinoma of the oral cavity 1 Endometrial cancer stage I 1 Pseudoxanthoma elasticum 1 Sjogren's syndrome 1 Peripheral artery restenosis 1

Top IMPs

ETIDRONATE DISODIUM 2 ACETYLSALICYLIC ACID 1 ALLOPURINOL SODIUM 1 ANAKINRA 1 ANGIOTENSIN II 1 AUTOLOGOUS CHONDROCYTES, REMESTEMCEL 1 BINIMETINIB 1 CANNABIDIOL 1 CISPLATIN 1 CLOPIDOGREL 1 DARBEPOETIN ALFA 1 DRONABINOL, CANNABIDIOL 1

All trials

37 total

RECLAIM: an Adaptive Platform Trial for the Evaluation of Treatments for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Not authorised

2024-511580-28-00 Phase III 1 country
A randomized, placebo-controlled, double blind trial to study the effects of Etidronate on ectopic CALCIfication in FAhr’s Disease or syndro… Pending

2024-512300-19-00 Phase II 1 country ETIDRONATE DISODIUM
mFBG PET-CT scan for the imaging of pheochromocytoma Pending

2024-513622-35-00 Phase II 1 country M-(18F)-FLUOROBENZYLGUANIDINE
ESTIS trial: Early Stop of targeted Treatment in children with Systemic JIA. Pending

2024-518684-35-00 Phase IV 1 country ANAKINRA
FIDES: Focused Ultrasound-mediated Blood-Brain Barrier Opening In Pontine Diffuse Midline Glioma (DMG) to Enhance Systemic Therapy with Temo… Pending

2025-520814-78-00 Phase I/II 1 country TEMOZOLOMIDE
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for bipolar depression compared… Recruiting

2023-506605-19-00 Phase III 5 countries
Cannabidiol in refractory childhood epilepsy, a personalized high-quality approach Recruiting

2023-507843-12-01 Phase III 1 country DRONABINOL, CANNABIDIOL
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for schizophrenia compared to t… Recruiting

2023-506602-39-00 Phase IV 4 countries
CeRebrUm and CardIac protection with ALlopurinol in Neonates with Critical Congenital Heart Disease requiring Cardiac Surgery with Cardiopul… Recruiting

2024-513041-37-00 Phase III 1 country ALLOPURINOL SODIUM
Angiotensin II for more effective radioembolization in liver cancer: the RADIANT study Recruiting

2025-521870-33-00 Phase II 1 country ANGIOTENSIN II
Setmelanotide in the ROHHAD-syndrome (ROH-SET study) Recruiting

2024-516753-45-00 Phase II 1 country SETMELANOTIDE
RECLAIM: an Adaptive Platform Trial for the Evaluation of Treatments for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Recruiting

2024-511580-28-02 Phase III 1 country
The detection of tumor-associated fibrosis in colorectal peritoneal metastases by FAPI-PET (TROMPET) Recruiting

2024-512301-16-01 Phase I (Other) 1 country
MANUS trial Recruiting

2024-515387-31-00 Phase II 1 country HUMAN MESENCHYMAL STEM CELLS
BOOSTCAMP: Boosting the endocannabinoid system before the treatment of anxiety symptoms Recruiting

2024-514783-78-00 Phase II 1 country CANNABIDIOL
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for major depressive disorder c… Recruiting

2023-506617-21-00 Phase III 5 countries
Darbepoetin for neonatal stroke Recruiting

2024-513042-12-01 Phase II 1 country DARBEPOETIN ALFA
Molecular imaging with FAPI for diagnosing the CSM4 colorectal cancer subtype Recruiting

2023-509183-17-00 Phase I (Other) 1 country
Treatment of cancer with Immune Checkpoint Inhibition therapy boosted by High Intensity Focused Ultrasound Histotripsy (the iFOCUS study) Recruiting

2023-509210-10-00 Phase I (Other) 1 country
CLEAR-PATH trial Recruiting

2024-513363-15-01 Phase III/IV 1 country ACETYLSALICYLIC ACID; CLOPIDOGREL
Sentinel lymph node biopsy in patients with parotid gland carcinoma using a combination of 99mTc-nanocolloid and 68Ga-tilmanocept PET/CT: A … Recruiting

2024-514233-37-00 Phase III 1 country
Pharmacokinetic-guided dosing of emicizumab in congenital haemophilia A patients – The DosEmi study Recruiting

2024-515528-35-00 Phase III/IV 1 country EMICIZUMAB
TEMP-PREVENT Ended

2024-512133-33-00 Phase III 1 country ETIDRONATE DISODIUM
Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiation in sarcopenic head and neck cancer patients Ended

2024-514919-10-00 Phase IV 1 country CISPLATIN

Showing 1–24 of 37 trials

← All sponsors A–Z